Huiying Kang1, Ningning Zhang, Kaining Shi2, Yanqiu Lv1, Di Hu1, and Yun Peng1
1Imaging center, Beijing Children’s Hospital, Capital Medical University, Beijing, China, People's Republic of, 2Imaging Systems Clinical Science, Philips Healthcare, Beijing, China, People's Republic of
Synopsis
Increasing
clinical studies suggested that there are some type Ⅰ
Gaucher disease (GDⅠ) patients suffering neurological
symptom, which was originally defined as non-neuropathlogical involved. This
study recruited 38 patients and 32 normal children to investigate morphological
changes of brain in GDⅠ patients by
using Diffusion Kurtosis Imaging. Our results showed significant decreased MD
in bilateral olfactory gyrus, increased MD in right calcarine and substantia
nigra and significant increased MK in right olfactory gyrus. Our
study suggests a necessity of adjusting the opinion regarding the
CNS-involvement of GDⅠ, and DKI
analysis is a potential imaging marker in clinical studies of GDⅠ.Purpose
Gaucher disease is a common genetic lysosomal storage
disorder which results from a deficiency of the lysosomal enzyme
glucocerebrosidase. Traditionally, brain
was deemed as spared in patients of type Ⅰ Gaucher disease. However, a few recent work has
reported that more than 36% to 49% type Ⅰ Gaucher disease patients suffering at least one
neurological symptom
1,2.Parkinson
disease or parkinsonian symptoms have also been reported as an incidental
association with type Ⅰ
Gaucher disease recently
3. Moreover,
an autopsy study has observed astrogliosis in cerebral cortical layers 3 and 5,
hippocampal CA2-4, and layer 4b in type Ⅰ Gaucher disease patients
4. It has been suggested that Gaucher disease’s
neuropathology process should be considered as a continuum phenotype, rather
than a discrete predefined classification
5 .In this work, Diffusion Kurtosis Imaging (DKI) was used to
investigate the potential morphological change in hippocampal, olfactory gyrus,
calcarine and substania nigra of type Ⅰ
Gaucher disease patients, according to the previous findings
4,6 .
Methods
38 type Ⅰ
Gaucher disease children patients and 32 normal children were recruited in this
study, with the approve of local IRB. All normal children had no history of
neurological or psychiatric illness. MR images were scanned using a 3T Philips
Achieva TX scanner. High-resolution anatomical images were acquired using a
three-dimensional gradient echo sequence with following parameters: Whole brain
coverage, TE/TR =3.8/8.3 ms, FA = 12, slice thickness of 1mm, matrix size =
180×180, FOV=180×200×160. Diffusion Kurtosis images were acquired using a single shot echo planar imaging applied in 15
non-collinear directions and a b-value of 0,1000,2000 s/mm2: TR = 8760
ms, TE = 92 ms, field of view = 224 mm × 224 mm, acquisition matrix = 112 × 112,
70 slices were acquired with a slice thickness of 2.0 mm and no gap.
MD
and MK maps were calculated by using the Diffusional Kurtosis Estimator (DKE) (www.nitrc.org/projects/dke). Regions of interest (ROIs) of bilateral olfactory
gyrus , calcarine
, hippocampus and substania nigra were
determined by ALL and TD brodmann areas template.
T test was used to detect the group difference of MD and MK value between type Ⅰ Gaucher disease patients and controls. Statistical significance
level of P<0.05 was considered as significant.
Result and Discussion
Compared
with healthy controls, significant decrease of MD in type Ⅰ Gaucher disease patients was found in the bilateral olfactory
gyrus and increases in right calcarine and substantia nigra.
Significant increase of MK in type Ⅰ
Gaucher disease patients was found in the right olfactory gyrus. The MD and MK
changes in olfactory are relevant to maybe the astrogliosis
7 and
these changes are compatible with a previous study which reported that patients
with Gaucher disease had the significantly lower olfactory function scores than
controls
6. The MD changes in right calcarine and substantia nigra are
compatible with the previous autopsy study, may be relevant to the neuronal
loss.
Conclusion
This
preliminary study provides novel evidences for structural abnormalities in type
Ⅰ Gaucher disease patients, suggesting a necessity of
adjusting the opinion regarding the CNS-involvement of type Ⅰ Gaucher disease. Our findings also suggest that DKI
analysis is a potential imaging marker to monitor the brain change in type Ⅰ Gaucher disease.
Acknowledgements
No acknowledgement found.References
1 Chérin
P , Rose C , de Roux-serratrice C et al. The neurological manifestations of
Gaucher disease type 1:the French Observatoire on Gaucher disease (FROG) J
Inherit Metab Dis. 2010;33(4):331-338
2
Giraldo P, Capablo JL, Alfonso P, et al.Neurological manifestations in patients
with Gaucher disease and their relatives, it is just a coincidence? J Inherit
Metab Dis. 2011 ;34(3):781-787
3 Bultron
B, Kacena K, Pearson D,et al. The risk of Parkinson’s disease in type 1 Gaucher
disease J Inherit Metab Dis 2010 ;33(2):167-73.
4 Wong
K, Sidransky E, Verma A et al
Neuropathology provides clues to the pathophysiology of Gaucher disease.
Mol Genet Metab 2004 ;82(3):192-207.
5 Capablo
JL, Saenz de Cabezón A, Fraile J, et al. Neurological evaluation of patients
with Gaucher disease diagnosed as type 1.JNeurol Neurosurg Psychiatry.
2008;79(2):219-22.
6 McNeill
A1, Duran R, Proukakis C, et al Hyposmia and cognitive impairment in Gaucher
disease patients and carriers. Mov Disord. 2012 Apr;27(4):526-32
7 Sofroniew
MV, Vinters HV. Astrocytes: biology and pathology. Acta Neuropathol 2010;
119:7–35